acmefirewoodis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's only a matter of time before AMBS is trading near Jason Napadano's target of .20.
Shorting AMBS at the current share price makes no sense.
1,000% upside over the next year versus 10% downside.
AMBS is the best opportunity in the market to earn substantial profits over the next 18 months and beyond.
"The next Amgen in its infancy."
Follow the company on Twitter: @AmarantusBio
p.s. I noticed there was a buy order on Level 2 on Friday for 1,000,000 shares@.043 and another one for 1,000,000 shares@.04.
I still find it difficult to believe that anyone thinks that shorting AMBS at the current share price makes sense considering the number of realistic scenarios that could triple the share price at any time and trigger a substantial move higher from that level.
I expect to be able to post a "What were they thinking?" post in the not too distance future.
Follow the company on Twitter: @AmarantusBio
p.s. I'm investing a few dollars in the Mega Millions lottery where the odds of winning are about 295,000,000 to one so I think I can afford to invest a few dollar in AMBS where the odds are much better. Who's to say that AMBS won't be worth over $500,000,000 in a few years.
If the FED announces the start of tapering on Tuesday I suspect GSS could hit .40 on Wednesday.
Just saying!!!
It will be lower soon. Be patient.
Next Tuesday's Fed meeting will make or break "NUGT" short term. $22.00 or $35.00 on Wednesday.
Place your bet.
It's frustrating to see the share price continue to drop on relatively small volume.
Without news the shorts can walk it down. The key support area is .04. I'll be very surprised if it goes below .04 again. Let's hope a bottom is near.
Note to Gerald: A company update would be appreciated.
The share price reacts to news or the lack of it.
No news means lower share price.
You are correct.
Unfortunately penny stocks don't do well when there is no news. The shorts know there is little possibility of news between now and the first part of January. They're taking advantage of this to drive the price down.
I have a limit buy order in below .04 in the event it goes that low.
Mining stocks will drop 7-10% between now and the end of the year which means "NUGT" will drop between 21-30% from its current price.
This puts "NUGT"'s price in the $17.85 to $20.64 range.
We'll see how my banter works out.
I'd be careful buying this for a next day bounce as a down trend may last several trading sessions.
p.s. Tax loss selling and funds dumping will hamper any recovery until next year.
Note: I don't see NUGT going below $15.00 as some posters have speculated.
Gold mining stocks are headed lower until the end of the year as retail investors sell for tax loss considerations and the funds dump for the end of the year "window dressing".
"GSS" below .40 is a 90% probability.
All IMHO.
Gold mining stocks are headed lower until the end of the year as retail investors sell for tax loss considerations and the funds dump for the end of the year "window dressing".
"NUGT" below $18.00 is a 90% probability.
All IMHO.
p.s. "DUST" is a better opportunity until next year.
AMBS is being "shorted" every day. The shorts need millions of shares to cover.
Anyone who says it isn't happening is out of touch with reality.
Welcome to the land of penny stocks.
Follow the company on Twitter: @AmarantusBio
$22.00 is possible.
Did you hear the one about.....!!! LOL!!!
The real question is where is the bottom in each camp: price of gold and value of the gold mining companies.
There are no experts that no where each is headed. Of this I am certain.
Back to $25.00 by the FED meeting next Tuesday.
Why is it that everyone keeps referring to the forced conversion of the warrants at .10?
There's any number of realistic events or scenarios under which the share price will be above .10 and the warrants will be converted "in the money".
Up listing to the NASDAQ in the second quarter of 2014 works for me. The talk of a reverse split to achieve the up listing is music to my ears.
Follow the company on Twitter: @AmarantusBio
p.s. I just can't imagine shorting AMBS at the current share price. The amount of stress would be unbearable. IMHO.
Don't try to catch a falling knife.
This is not a one day event. It is the new trend for gold which is up!!!
From your post to Gerald's ears.
I agree with your assessment.
Current share price is a great entry point.
Looks as though it closes below $40.00 today. Not going to be a pretty opening. Move away from the exits lest you get trampled.
The sellers will be chasing the bid.
I'm thinking $39.53 at the close.
p.s. Chart says it eventually goes to $35.00.
Ashes to ashes, "DUST" to dust.
Get out before it's too late.
Gold is about to run.
All IMHO.
p.s. Below $35.00 by Friday sounds reasonable.
Above $35.00 by tomorrow seems reasonable. Sector upgrades expected.
$35.00 seems logical.
Without news the shorts will hold it here.
"Merry Christmas" and a "Happy New Year" for the "NUGT" longs.
It was so obvious.
Did you short it again?
Who's shorting/selling a .50 stock for under six cents?
Just as those individuals that did so at four cents they'll regret it soon.
This is only one p.r. away from .20.
"2 Picks From Barron's 'Top Ten Stocks For 2014' List"
http://seekingalpha.com/article/1884091-2-picks-from-barrons-top-ten-stocks-for-2014-list?source=yahoo
Expect more companies to be upgraded in the gold mining sector.
Gold is oversold and so is "NUGT".
Is the Tide Finally Turning for Gold Miners?
http://www.fool.com/investing/general/2013/12/08/the-tide-could-be-turning-is-it-time-to-buy-gold-m.aspx
Is the Tide Finally Turning for Gold Miners?
http://www.fool.com/investing/general/2013/12/08/the-tide-could-be-turning-is-it-time-to-buy-gold-m.aspx
I'm expecting a reverse split just prior to the up listing to the NASDAQ in the second quarter of 2014 with subsequent news tripling the share price within three months.
I wouldn't be surprised to see AMBS's share price to be in the $3.00 range at the time of the up listing and being above $10.00 within three months or sooner.
$50.00 within two years after the uplisting.
MANF and LymPro could be worth billion$!!!
MANF "Second Orphan" Process of Elimination
Gerald has spoken about several indications the company is researching pertaining to MANF: 1) Parkinsons, 2) Traumatic Brain Injury (TBI), 3) Retinits, 4) Diabetes (Wolfram's Syndrome), & 5) Ischemic Heart Disease. These are the indications most spoken of. Other indications less spoken of include: Strokes, Hearing, and Organ Transplants, and perhaps a few others. But, of the main 5 indications Gerald focuses on we know that "Retinitis" isn't the "second orphan" because it is already the "first orphan" we've publically identified. Of the remaining four we know that Parkinsons and Ischemic Heart Disease don't qualify because they are not rare enough to qualify with the FDA as an "orphan disease." So that leaves TBI and Wolframs (a rare subset of Diabetes). At the Conference in L.A. last Tuesday I asked Gerald if he thought TBI would qualify as an "orphan?" The answer he gave me was not definitive, but he seemed to show doubt whether it was rare enough to qualify as an "orphan." Thus, by process of elimination that only leaves us with "Wolfram's Syndrome." Gerald told us several months ago that he had the data for the second orphan in hand and would be announcing it soon, but we heard nothing. We got Retinitis, but no second orphan. Then in the CC two weeks ago he said the reason he hasn't made it public yet is because it is still in "negotiations." "Negotiations?" Retinitis wasn't delayed because there wasn't a Partner revealed when they released the data. Could it be that the "second orphan" data will not be released until we have finalized the Partnership that will go along with it? I THINK SO. I THINK IT WILL BE "WOLFRAM'S SYNDROME." I don't know who the Partner will be but according to Dr. Urano who has conducted the testing for Wolframs, finding a cure for Wolframs is the same as finding a cure for Type 2 Diabetes!! I THINK WE HAVE FOUND A SHORT CUT TO COMMERCIALIZING A BREAKTHROUGH TREATMENT FOR TYPE 2 DIABETES!! THAT COULD BE HUGE!
Posted by riskreturn168 on the Yahoo board.
I think gold will be in the $1,772 range by the end of 2014.
Any move higher in ABX's share price is bad for DUST.
"2 Picks From Barron's 'Top Ten Stocks For 2014' List"
http://seekingalpha.com/article/1884091-2-picks-from-barrons-top-ten-stocks-for-2014-list?source=yahoo
Interesting week ahead.
Any move higher in ABX's share price is good for NUGT.
"2 Picks From Barron's 'Top Ten Stocks For 2014' List"
http://seekingalpha.com/article/1884091-2-picks-from-barrons-top-ten-stocks-for-2014-list?source=yahoo
Interesting week ahead.
"2 Picks From Barron's 'Top Ten Stocks For 2014' List"
http://seekingalpha.com/article/1884091-2-picks-from-barrons-top-ten-stocks-for-2014-list?source=yahoo
The shorts and the penny flippers will soon get left behind. The momentum to the upside is building.
The shorts are having to sell almost 50% of the daily volume to keep a lid on the share price. They keep digging their own grave deeper every trading session.
Soon it will be too deep for them to climb out.
Up listing to the NASDAQ the second quarter of 2014 seems reasonable enough.
Follow the company on Twitter: @AmarantusBio
Checkout the "stair step action" on the chart over the last six months. All things being equal a a fall back to the $35.00 range is in the offering.
Just saying.
p.s. Tread lightly.